TAT-Modified Gold Nanoparticle Carrier with Enhanced Anticancer Activity and Size Effect on Overcoming Multidrug Resistance
Author:
Affiliation:
1. Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, United States
Funder
Natural Science Foundation of Beijing Municipality
National Institute of Biomedical Imaging and Bioengineering
National Natural Science Foundation of China
Publisher
American Chemical Society (ACS)
Subject
General Materials Science
Link
https://pubs.acs.org/doi/pdf/10.1021/acsami.6b15200
Reference53 articles.
1. Multidrug resistance in cancer: role of ATP–dependent transporters
2. Targeting multidrug resistance in cancer
3. Metal-based anticancer chemotherapeutic agents
4. Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
5. P-Glycoprotein Kinetics Measured in Plasma Membrane Vesicles and Living Cells
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Upconversion nanoparticles–based targeted imaging of MCF-7 breast cancer cells;Journal of Nanoparticle Research;2024-06
2. Self-Assembly of Peptides as an Alluring Approach toward Cancer Treatment and Imaging;ACS Biomaterials Science & Engineering;2024-04-22
3. Influence of Gold Glyconanoparticles on the Functioning of P-Glycoprotein In Vitro;Nanobiotechnology Reports;2024-02
4. ABC transporter-mediated MXR mechanism in fish embryos and its potential role in the efflux of nanoparticles;Ecotoxicology and Environmental Safety;2023-09
5. Gold nanoparticle-based drug nanocarriers as a targeted drug delivery system platform for cancer therapeutics: a systematic review;Gold Bulletin;2023-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3